The Evolution of Duplicated Genes of the Cpi-17/Phi-1 (ppp1r14) Family of Protein Phosphatase 1 Inhibitors in Teleosts

被引:10
作者
Lang, Irene [1 ]
Virk, Guneet [1 ]
Zheng, Dale C. [1 ]
Young, Jason [1 ]
Nguyen, Michael J. [1 ]
Amiri, Rojin [1 ]
Fong, Michelle [1 ]
Arata, Alisa [1 ]
Chadaideh, Katia S. [1 ,2 ]
Walsh, Susan [3 ]
Weiser, Douglas C. [1 ]
机构
[1] Univ Pacific, Dept Biol Sci, Stockton, CA 98211 USA
[2] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA
[3] Soka Univ Amer, Life Sci, Aliso Viejo, CA 92656 USA
关键词
Danio rerio; Phi-1 (ppp1r14b); Cpi-17 (ppp1r14a); PP1; Mypt1; genome duplication; MYOSIN PHOSPHATASE; SMOOTH-MUSCLE; KINASE-C; PHOSPHOPROTEIN INHIBITOR; MEDIATED ACTIVATION; PHOSPHORYLATION; PKC; SPECIFICITY; EXPRESSION; REGULATOR;
D O I
10.3390/ijms21165709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Cpi-17 (ppp1r14) gene family is an evolutionarily conserved, vertebrate specific group of protein phosphatase 1 (PP1) inhibitors. When phosphorylated, Cpi-17 is a potent inhibitor of myosin phosphatase (MP), a holoenzyme complex of the regulatory subunit Mypt1 and the catalytic subunit PP1. Myosin phosphatase dephosphorylates the regulatory myosin light chain (Mlc2) and promotes actomyosin relaxation, which in turn, regulates numerous cellular processes including smooth muscle contraction, cytokinesis, cell motility, and tumor cell invasion. We analyzed zebrafish homologs of the Cpi-17 family, to better understand the mechanisms of myosin phosphatase regulation. We found single homologs of both Kepi (ppp1r14c) and Gbpi (ppp1r14d) in silico, but we detected no expression of these genes during early embryonic development. Cpi-17 (ppp1r14a) and Phi-1 (ppp1r14b) each had two duplicate paralogs, (ppp1r14aaandppp1r14ab) and (ppp1r14baandppp1r14bb), which were each expressed during early development. The spatial expression pattern of these genes has diverged, withppp1r14aaandppp1r14bbexpressed primarily in smooth muscle and skeletal muscle, respectively, whileppp1r14abandppp1r14baare primarily expressed in neural tissue. We observed that, in in vitro and heterologous cellular systems, the Cpi-17 paralogs both acted as potent myosin phosphatase inhibitors, and were indistinguishable from one another. In contrast, the two Phi-1 paralogs displayed weak myosin phosphatase inhibitory activity in vitro, and did not alter myosin phosphorylation in cells. Through deletion and chimeric analysis, we identified that the difference in specificity for myosin phosphatase between Cpi-17 and Phi-1 was encoded by the highly conserved PHIN (phosphatase holoenzyme inhibitory) domain, and not the more divergent N- and C- termini. We also showed that either Cpi-17 paralog can rescue the knockdown phenotype, but neither Phi-1 paralog could do so. Thus, we provide new evidence about the biochemical and developmental distinctions of the zebrafish Cpi-17 protein family.
引用
收藏
页码:1 / 23
页数:23
相关论文
共 6 条
  • [1] Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase
    Deng, JT
    Sutherland, C
    Brautigan, DL
    Eto, M
    Walsh, MP
    BIOCHEMICAL JOURNAL, 2002, 367 : 517 - 524
  • [2] Regulation of Cellular Protein Phosphatase-1 (PP1) by Phosphorylation of the CPI-17 Family, C-kinase-activated PP1 Inhibitors
    Eto, Masumi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (51) : 35273 - 35277
  • [3] Phospho-pivot modeling predicts specific interactions of protein phosphatase-1 with a phospho-inhibitor protein CPI-17
    Matsuzawa, F
    Aikawa, S
    Ohki, S
    Eto, M
    JOURNAL OF BIOCHEMISTRY, 2005, 137 (05) : 633 - 641
  • [4] Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells
    Eto, Masumi
    Kirkbride, Jason A.
    Chugh, Rishika
    Karikari, Nana Kofi
    Kim, Jee In
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 434 (01) : 137 - 142
  • [5] Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer
    Liao, Li
    Zhang, Yin -Ling
    Deng, Ling
    Chen, Chao
    Ma, Xiao-Yan
    Andriani, Lisa
    Yang, Shao-Ying
    Hu, Shu-Yuan
    Zhang, Fang-Lin
    Shao, Zhi-Min
    Li, Da-Qiang
    CANCER RESEARCH, 2023, 83 (03) : 471 - 484
  • [6] Volatile Anesthetics Inhibit Angiotensin II-Induced Vascular Contraction by Modulating Myosin Light Chain Phosphatase Inhibiting Protein, CPI-17 and Regulatory Subunit, MYPT1 Phosphorylation
    Qi, Feng
    Ogawa, Koji
    Tokinaga, Yasuyuki
    Uematsu, Nobuhiko
    Minonishi, Toshiyuki
    Hatano, Yoshio
    ANESTHESIA AND ANALGESIA, 2009, 109 (02) : 412 - 417